Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Meyer-Lindenberg, Andreas, Miletich, Robert S., Kohn, Philip D., Esposito, Giuseppe, Carson, Richard E., Quarantelli, Mario, Weinberger, Daniel R., Berman, Karen Faith·2002·Nature Neuroscience
DOI 10.1038/nn804

Cited by (646)

Items 601–646 of 646

  1. Effects of aripiprazole vs. haloperidol on brain activity in healthy volunteers
    Ingeborg Bolstad · 2016 · NORA - Norwegian Open Research Archives
  2. Function and dysfunction of the prefrontal cortex: effects of distraction on active maintenance in healthy controls and individuals with schizophrenia
    Sarah J. Hart · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  3. Functional neuroimaging of pathophysiological mesolimbic dopamine system and aberrant motivational salience in schizophrenia
    Anja Richter · 2017
  4. Pathophysiological changes of neurofunctional interaction between the dopaminergic reward system and the hippocampus in schizophrenia and bipolar disorder
    Sarah Wolter · 2018
  5. Identifying neural underpinnings of schizophrenia-specific disruptions in cognition using magnetic resonance imaging, individual differences, and genetics
    Amanda Rodrigue · 2017
  6. The Long-term Effects of Chronic Antipsychotic Drug Treatment in Juvenile Rats on Adult Behavioural Attributes, Dopamine and Serotonin Neurotransmitter Systems
    Michael De Santis · 2018 · Research Online (University of Wollongong)
  7. Neurocognitive deficits in participants at clinical high-risk for psychosis: relationships to clinical symptoms and functioning
    Lucy Mitchell · 2018 · Enlighten: Theses (The University of Glasgow)
  8. Mapping common ground: relationships between sensory-processing sensitivity, introversion-extraversion, openness to experience and intelligence
    Jodie Valpied · 2018 · Minerva Access (University of Melbourne)
  9. Working Memory-Related Prefrontal Activity Measured with Magnetoencephalography: Abnormalities in Schizophrenia and Relationship to Dopamine
    Daniel Rubinstein · 2017
  10. Mecanismos de acción de los medicamentos antipsicóticos de segunda generación en la esquizofrenia: conocimientos obtenidos a partir de los estudios de imágenes cerebrales
    Anissa Abi‐Dargham, Marc A. Laruelle · 2005 · European psychiatry (Ed Española)
  11. Some animal models are more equal than others: Cortico-striatal circuits for translation
    Megan E. Monko, Sarah R. Heilbronner · 2020 · Lab Animal
  12. The Impact of Genetic Polymorphisms on Neuroreceptor Binding: Results from PET and SPECT Neuroreceptor Imaging Studies
    Irene Graf, Matthäus Willeit, Siegfried F. Kasper, Nicole Praschak-Rieder · 2020 · Springer eBooks
  13. Extrastriatal dopamine D2/3 receptors in schizophrenia
    Heli Tuppurainen · 2011 · UEF eRepo (University of Eastern Finland)
  14. Investigating Cortical Dopamine Release due to a Cognitive Challenge in Clinical High-risk: A [11C]FLB457 Positron Emission Tomography Study
    Abanti Tagore · 2019 · TSpace (University of Toronto)
  15. Pathophysiologische Veränderungen spezifischer neurofunktioneller Systeme bei Schizophrenie
    Aleksandra Dechent · 2021
  16. Towards personalized treatment of clozapine
    Cynthia Okhuijsen‐Pfeifer · 2021
  17. Dopamine, Cognitive Flexibility and IQ: Epistatic COMT:DRD2 Gene-Gene Interactions Modulate Mental Rigidity
    Leor Zmigrod, Trevor Robbins · 2021
  18. Schizophrenie
    Christian Eggers, Bernd Röpcke · 2011 · Springer eBooks
  19. Schizophrenia
    2006 · Wiley eBooks
  20. Psychoneurobiology Research and Personalized Treatment of Schizophrenia
    Tomiki Sumiyoshi · 2022 · MDPI eBooks
  21. 多巴胺通路的基因与精神分裂症风险的多位点关联研究
    孙向青, 贾彦彬, 张学工, 许琪, 沈岩, 李衍达 · 2004 · Science in China Series C-Life Sciences (in Chinese)
  22. Neuroimaging of Psychotic Disorders
    Stephan Heckers, Neil D. Woodward, Döst Öngür · 2017 · Oxford University Press eBooks
  23. Decision-Making, Behavioral Supervision and Learning: An Executive Role for the Ventral Premotor Cortex?
    Carlos Acuña, José L. Pardo‐Vázquez, Víctor Leborán · 2013 · Springer eBooks
  24. As bases biológicas da Esquizofrenia
    Diana Pinto Prata · 2015 · Imprensa da Universidade de Coimbra eBooks
  25. Investigação das bases biológicas da cognição na esquizofrenia com Imagiologia Genética
    Diana Pinto Prata · 2015 · Imprensa da Universidade de Coimbra eBooks
  26. Developmental Manipulation-Induced Changes in Cognitive Functioning
    Sahith Kaki, Holly DeRosa, Brian M. Timmerman, Susanne Brummelte, Richard G Hunter, Amanda C. Kentner · 2022 · Current topics in behavioral neurosciences
  27. Neurotransmitters of the Nervous System-Characterization and Methodological Approaches to the Study Using Monoclonal Antibodies
    Н. Е. Максимович, Bon EI, Никита Витальевич Кохан, B Th Vihang · 2023 · Journal of Clinical Research and Case Studies
  28. The circuit mechanisms of working memory: Key roles of the dorsolateral prefrontal cortex
    Amy F.T. Arnsten, Julio Martínez-Trujillo · 2024 · Elsevier eBooks
  29. IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia
    Hugo Geerts · 2025 · Pharmacological Research
  30. ZFHX4 is necessary for dopaminergic neuron differentiation and controls cell cycle by regulating LIN28A
    Elena Valceschini, Borja Gomez Ramos, Jochen Ohnmacht, Aurélien Ginolhac, Marie Catillon, Déborah Gérard, Anthoula Gaigneaux, Dimitrios Kyriakis, Kamil Grzyb, Enrico Glaab et al. · 2026 · Stem Cell Reports
  31. Dopamine systems in impulsive–compulsive behavior
    Trevor William Robbins, Jeffrey W. Dalley · 2025 · Handbook of behavioral neuroscience
  32. Acute systemic immune challenge induces cognitive impairments and anhedonia through interferon-induced transmembrane protein 3 in adult male mice
    Wenjun Zhu, Akira Sobue, Rinako Tanaka, Kazuhiro Hada, Daisuke Ibi, Yue Liu, Tetsuo Matsuzaki, Taku Nagai, Toshitaka Nabeshima, Kozo Kaibuchi et al. · 2025 · Behavioural Brain Research
  33. Structural and functional cerebral changes in patients with schizophrenia and genetic risk-allele carriers
    Joseph P. Kambeitz · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  34. Connecting the dots : new perspectives on stress and psychosis
    Johan Lataster · 2012
  35. Additional file 1 of Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
    Tertia D. Purves-Tyson, Amelia M. Brown, Christin Weissleder, Debora A. Rothmond, Cynthia Shannon-Weickert · 2021 · Figshare
  36. Dopamine Modulation by Antipsychotic in Schizophrenia
    Verma Muskan · 2025 · International Journal of Medical Research and Innovation
  37. Opposite effects of DRD2 gene polymorphisms on inhibitory control and motor output in antisaccade task in healthy subjects and schizophrenia patients
    Anna V. Kirenskaya, Vladimir Yu Novototsky-Vlasov, Alexander O. Kibitov, Tamara V. Merkulova, Andrej A. Tkachenko, Zinaida I. Storozheva · 2026 · Molecular Biology Reports
  38. Rôle de la protéine phosphatase 1 dans les mécanismes d’action de la cocaïne et implication des modifications épigénétiques dans sa régulation
    Sarah Pol Bodetto · 2012 · theses.fr (ABES)
  39. Les longs ARN non codants, une nouvelle classe de régulateurs génomique tissu-spécifique : signature moléculaire spécifique des neurones dopaminergiques et sérotoninergiques
    Judith Gendron · 2017
  40. Exploration des corrélats neurofonctionnels des théories de l’esprit affective et cognitive dans la schizophrénie : l’étude en imagerie cérébrale fonctionnelle
    Ksenija Vucurovic · 2021
  41. Effects of Δ 9 -tetrahydrocannabinol on affiliative social behaviour: A systematic review of rodent studies
    Mashal Ahmed, Christina F. Pereira, Laura M. Best, Raesham Mahmood, Tony Peter George, Bernard Le Foll, Isabelle Boileau, Stefan Kloiber · 2026 · Journal of Psychopharmacology
  42. Circuit mechanisms of psychotic symptoms across disorders
    Urs Braun, Johannes Wolf, Dušan Hirjak, Emanuel Schwarz, Heike Tost, Andreas Meyer‐Lindenberg · 2026 · Neuron
  43. BindingDB Entry 5480: Dihydrexidine--the first full dopamine D1 receptor agonist.
    BindingDB · 2012 · UC San Diego
  44. Les effets d’un traitement chronique aux antipsychotiques sur la poursuite d’une récompense conditionnée
    Anne-Marie Bédard · 2011
  45. Once upon a spine: setting striatal dopamine
    Christoph Kellendonk, Joshua A. Gordon · 2015 · Nature Neuroscience
  46. Neurogenetic Risk Mechanisms of Schizophrenia: An Imaging Genetics Approach
    Andreas Meyer‐Lindenberg · 2009 · Springer eBooks